Cost-effective therapies for HCC: Resection and ablation
Küçük Resim Yok
Tarih
2021
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Springer International Publishing
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Liver transplantation is the most effective option for the treatment of both HCC and underlying chronic liver disease. The stage of the disease, liver function, tumor biology, and concomitant diseases are determinant in the treatment approach. In addition to these, the capacity of the center, the experience of doctors in liver disease treatment, the economic share allocated to the health system, and equipment and trained personnel play an important role in determining the treatment. Surgical resection and some of the local ablative treatments such as PEI, RFA, and MWA can provide comparable results to liver transplantation at a lower cost in selected patients. On the other hand, the cost of the procedures is not standard, with many variables, and reveals differences between social security coverage of the countries. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2021. All rights reserved.
Açıklama
Anahtar Kelimeler
Hepatocellular carcinoma, Microwave ablation, Percutaneous ethanol injection, Radiofrequency ablation, Resection
Kaynak
Liver Cancer in the Middle East
WoS Q Değeri
Scopus Q Değeri
N/A
